Pasithea Therapeutics (KTTA) Other Non Operating Income (2022 - 2024)
Historic Other Non Operating Income for Pasithea Therapeutics (KTTA) over the last 3 years, with Q2 2024 value amounting to $114407.0.
- Pasithea Therapeutics' Other Non Operating Income fell 237.56% to $114407.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $378428.0, marking a year-over-year decrease of 5917.22%. This contributed to the annual value of $471613.0 for FY2023, which is 4523.04% down from last year.
- According to the latest figures from Q2 2024, Pasithea Therapeutics' Other Non Operating Income is $114407.0, which was down 237.56% from $153218.0 recorded in Q1 2024.
- In the past 5 years, Pasithea Therapeutics' Other Non Operating Income registered a high of $816086.0 during Q4 2022, and its lowest value of -$6388.0 during Q1 2023.
- Moreover, its 3-year median value for Other Non Operating Income was $115799.0 (2023), whereas its average is $206585.7.
- In the last 5 years, Pasithea Therapeutics' Other Non Operating Income plummeted by 11419.56% in 2023 and then skyrocketed by 249852.85% in 2024.
- Pasithea Therapeutics' Other Non Operating Income (Quarter) stood at $816086.0 in 2022, then crashed by 85.64% to $117191.0 in 2023, then fell by 2.38% to $114407.0 in 2024.
- Its Other Non Operating Income was $114407.0 in Q2 2024, compared to $153218.0 in Q1 2024 and $117191.0 in Q2 2023.